SCHEMBL23875151

SCHEMBL23875151

CN[C@H](C)CCCc1ccc(O)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 3/20 0.50
TMEM97 Q5BJF2 1/20 0.50
OPRK1 P41145 2/20 0.49
ESR1 P03372 3/20 0.48
ADRA2A P08913 3/20 0.48
ADORA3 P0DMS8 3/20 0.48
SLC6A2 P23975 3/20 0.48
SLC6A4 P31645 3/20 0.48
SLC6A3 Q01959 3/20 0.48
KDM4E B2RXH2 3/20 0.48
LMNA P02545 3/20 0.48
TACR2 P21452 2/20 0.48
CYP3A4 P08684 2/20 0.48
HIF1A Q16665 2/20 0.48
HSD17B10 Q99714 2/20 0.48
EGFR P00533 2/20 0.48
LCK P06239 2/20 0.48
ADRA2B P18089 2/20 0.48
ADRA2C P18825 2/20 0.48
PTGS2 P35354 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9628206 1.00 SIGMAR1 (0.50) SIGMAR1TMEM97OPRK1ESR1ADRA2A
SCHEMBL487003 0.90 SIGMAR1 (0.43) SIGMAR1SLC6A4HTT
SCHEMBL18182128 0.89 OPRK1 (0.60) SIGMAR1TMEM97OPRK1ESR1ADRA2A
SCHEMBL15907606 0.81 SIGMAR1 (0.59) SIGMAR1MEN1KMT2A
SCHEMBL104946 0.80 ESR1 (0.55) SIGMAR1TMEM97OPRK1ESR1ADRA2A
SCHEMBL9627281 0.79 HTT (0.57) SIGMAR1KDM4EALDH1A1CALM1MAPK1
SCHEMBL692205 0.79 ESR1 (0.53) SIGMAR1TMEM97OPRK1ESR1ADRA2A
SCHEMBL11573656 0.76 ESR1 (0.47) SIGMAR1TMEM97OPRK1ESR1ADRA2A
Pholedrine SCHEMBL119262 0.76 TAAR1 (0.63) SIGMAR1ESR1ADORA3SLC6A2SLC6A4
Pholedrine SCHEMBL15286090 0.76 TAAR1 (0.63) SIGMAR1ESR1ADORA3SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195401-A1 TECHNOLOGIES FOR PREVENTING OR TREATING INFECTIONS BIOHAVEN THERAPEUTICS LTD. (US) 2021-09-30 WO disclosed